The University of Oxford has started the phase 1 clinical trials on 54 healthy adults to investigate intranasal inoculation with the vaccine it developed with AstraZeneca (ChAdOx1 nCoV-19/AZD1222) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results